Cargando…

Nanomaterial Delivery Systems for mRNA Vaccines

The recent success of mRNA vaccines in SARS-CoV-2 clinical trials is in part due to the development of lipid nanoparticle delivery systems that not only efficiently express the mRNA-encoded immunogen after intramuscular injection, but also play roles as adjuvants and in vaccine reactogenicity. We pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buschmann, Michael D., Carrasco, Manuel J., Alishetty, Suman, Paige, Mikell, Alameh, Mohamad Gabriel, Weissman, Drew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836001/ https://www.ncbi.nlm.nih.gov/pubmed/33478109 http://dx.doi.org/10.3390/vaccines9010065

Ejemplares similares

Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration
por: Carrasco, Manuel J., et al.
Publicado: (2021)

A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria
por: Chuang, Yu-Min, et al.
Publicado: (2023)

Ionizable lipid nanoparticles for in utero mRNA delivery
por: Riley, Rachel S., et al.
Publicado: (2021)

mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
por: Sittplangkoon, Chutamath, et al.
Publicado: (2022)

mRNA vaccines for infectious diseases: principles, delivery and clinical translation
por: Chaudhary, Namit, et al.
Publicado: (2021)

Author Correction: mRNA vaccines for infectious diseases: principles, delivery and clinical translation
por: Chaudhary, Namit, et al.
Publicado: (2021)

Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
por: Liu, Wei, et al.
Publicado: (2022)

Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
por: Shepherd, Sarah J., et al.
Publicado: (2023)

An ionizable lipid toolbox for RNA delivery
por: Han, Xuexiang, et al.
Publicado: (2021)

Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine
por: Hook, Lauren M., et al.
Publicado: (2022)

SARS-CoV-2 mRNA-based vaccines in the Aicardi Goutières Syndrome
por: Takanohashi, Asako, et al.
Publicado: (2022)

Debunking mRNA Vaccine Misconceptions—An Overview for Medical Professionals
por: Hitti, Frederick L., et al.
Publicado: (2021)

mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
por: Hayashi, Clifford T. H., et al.
Publicado: (2022)

Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
por: Hayashi, Clifford T. H., et al.
Publicado: (2023)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
por: Melamed, Jilian R., et al.
Publicado: (2023)

Development and Delivery Systems of mRNA Vaccines
por: Liang, Yongjun, et al.
Publicado: (2021)

Delivery Strategies for mRNA Vaccines
por: Ramachandran, Sivakumar, et al.
Publicado: (2022)

The Delivery of mRNA Vaccines for Therapeutics
por: Nitika,, et al.
Publicado: (2022)

Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
por: Han, Xuexiang, et al.
Publicado: (2023)

Corrigendum: Development and Delivery Systems of mRNA Vaccines
por: Liang, Yongjun, et al.
Publicado: (2021)

Development of mRNA Vaccines/Therapeutics and Their Delivery System
por: Son, Sora, et al.
Publicado: (2023)

Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus
por: Furey, Colleen, et al.
Publicado: (2023)

Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice
por: Prompetchara, Eakachai, et al.
Publicado: (2023)

mRNA vaccines: A matter of delivery
por: Cao, Yuhong, et al.
Publicado: (2021)

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
por: Karikó, Katalin, et al.
Publicado: (2011)

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
por: Tombácz, István, et al.
Publicado: (2021)

Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
por: Li, De‐feng, et al.
Publicado: (2023)

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1
por: Egan, Kevin P., et al.
Publicado: (2023)

Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
por: Tang, Jinyi, et al.
Publicado: (2022)

Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
por: Wadhwa, Abishek, et al.
Publicado: (2020)

Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
por: Hajnik, Renee L., et al.
Publicado: (2022)

UDP-glucose dehydrogenase (UGDH) activity is suppressed by peroxide and promoted by PDGF in fibroblast-like synoviocytes: Evidence of a redox control mechanism
por: Chandrasekaran, Ramya, et al.
Publicado: (2022)

Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
por: Wang, Yusi, et al.
Publicado: (2022)

2342. Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model
por: England, Ross N, et al.
Publicado: (2023)

Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity
por: Patra, Tapas, et al.
Publicado: (2023)

The nano delivery systems and applications of mRNA
por: Li, Mingyuan, et al.
Publicado: (2022)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin
por: Karikó, Katalin, et al.
Publicado: (2012)

Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa
por: Tang, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_di0tjn91iv2dh21aivrj66rbpq